Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|16|9|531-536

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.9, 2015-09, pp. : 531-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Adrenomedullin and Subclinical Cardiorenal Syndrome in Patients with Type 2 Diabetes Mellitus

By Pecková M Charvat J Schuck O Zamrazil V Bilek R Hill M Svab P Horackova M

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1552-1559

Field House Publishing

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Treatment of Heart Failure in Patients with Diabetes Mellitus

By Lavine S.J. Gellman S.D.

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 285-307

Adis International

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite